Story preview
Continue reading on the publisher site for the full article.
Read on publisher →Yahoo Finance
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
5
in the last 3 days
First reported
28 hr. ago
4 outlets since
Countries
4 other outlets reported this story in the last 3 days.
Gilead Sciences, Inc. (NASDAQ:GILD) shares are up more than 24% this year, ahead of the S&P 500’s 14%. Gilead makes HIV, liver disease and cancer drugs. The stock is part of our coverage of the 8 best-performing stock picks by Claude AI in 2026. Why Gilead Stock Is Up Gilead Q2 sales rose 10% year […]
Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing.